Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

Add To Watchlist

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > I'm fairly. Sure more dilution is on the way

View:

Post by YukonJezza on Dec 27, 2020 2:54pm

I'm fairly. Sure more dilution is on the way

and if the reverse split was just a tool to do more raises than this will drop fast.

204

Comment

Comment by MrMugsy on Dec 27, 2020 3:27pm

More dilution will eventually happen - but - I storngly doubt it happens at this price. The reverse split is just a tool that needs to be deployed and I suggest the winning way is as follows ... 1. Move to TSX from Venture. 2. Split. 3. Drive share price up ... this is where we're at over the next couple months - offering news on the R&D side and on the business ...more

243

Comment

Comment by Marky1 on Dec 27, 2020 3:49pm

Wow, that was fantastic Mugsy! I totally agree on all your points, except for one...I don't think that more dilution will be happening...I think that ANTIBE will work out with a partnering deal whereby the Pharma company pays for the the P3 testing in its entirety and have the right of first refusal to buy 346. and the whole line of H2S drugs...Win win for an astute company such as Pfizer

165

Comment